EVALUATION, OPTION AND LICENSE AGREEMENTEvaluation, Option and License Agreement • March 6th, 2020 • Ayala Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 6th, 2020 Company Industry JurisdictionCertain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
EVALUATION, OPTION AND LICENSE AGREEMENTEvaluation, Option and License Agreement • February 12th, 2020 • Ayala Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 12th, 2020 Company Industry JurisdictionCertain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.